LOCOID Drug Patent Profile
✉ Email this page to a colleague
When do Locoid patents expire, and what generic alternatives are available?
Locoid is a drug marketed by Bausch, Yamanouchi, and Precision Dermat. and is included in eight NDAs. There is one patent protecting this drug and one Paragraph IV challenge.
The generic ingredient in LOCOID is hydrocortisone butyrate. There are sixty-seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrocortisone butyrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Locoid
A generic version of LOCOID was approved as hydrocortisone butyrate by TARO PHARM INDS on January 14th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LOCOID?
- What are the global sales for LOCOID?
- What is Average Wholesale Price for LOCOID?
Summary for LOCOID
US Patents: | 1 |
Applicants: | 3 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Clinical Trials: | 4 |
Patent Applications: | 5,712 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LOCOID |
What excipients (inactive ingredients) are in LOCOID? | LOCOID excipients list |
DailyMed Link: | LOCOID at DailyMed |
![LOCOID drug patent expirations Drug patent expirations by year for LOCOID](/p/graph/s/t/LOCOID-patent-expirations.png)
![Drug Prices for LOCOID](/p/graph/drug-price/LOCOID.png)
![Drug Sales Revenue Trends for LOCOID](/p/graph/drug-sales-revenues/LOCOID.png)
Recent Clinical Trials for LOCOID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
LEO Pharma | Phase 1 |
Icahn School of Medicine at Mount Sinai | N/A |
GlaxoSmithKline | Phase 4 |
Pharmacology for LOCOID
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Paragraph IV (Patent) Challenges for LOCOID
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
LOCOID | Lotion | hydrocortisone butyrate | 0.10% | 022076 | 1 | 2016-08-31 |
US Patents and Regulatory Information for LOCOID
LOCOID is protected by one US patents.
Patents protecting LOCOID
Stabilized steroid composition and method for its preparation
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | LOCOID | hydrocortisone butyrate | CREAM;TOPICAL | 018514-001 | Mar 31, 1982 | AB1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Yamanouchi | LOCOID | hydrocortisone butyrate | SOLUTION;TOPICAL | 019819-001 | Sep 15, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Precision Dermat | LOCOID | hydrocortisone butyrate | OINTMENT;TOPICAL | 018652-001 | Oct 29, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Precision Dermat | LOCOID LIPOCREAM | hydrocortisone butyrate | CREAM;TOPICAL | 020769-001 | Sep 8, 1997 | AB2 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Yamanouchi | LOCOID | hydrocortisone butyrate | CREAM;TOPICAL | 018795-001 | Jan 7, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bausch | LOCOID | hydrocortisone butyrate | LOTION;TOPICAL | 022076-001 | May 18, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
Bausch | LOCOID | hydrocortisone butyrate | SOLUTION;TOPICAL | 019116-001 | Feb 25, 1987 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |